Pharmaceuticals, Diagnostics
Swiss multinational healthcare company (SIX: ROG) — world's largest pharma by revenue 2023. Combines pharmaceuticals + diagnostics. CHF 58bn revenue. 103,000+ employees. Roche Thailand + Roche Diagnostics (Thailand) operate in oncology, diabetes care, and in-vitro diagnostics.
Composite score across 5 categories MNCs operating in Thailand can demonstrate.
How this is computed: a weighted average of 5 sub-scores. Higher weight on signals an MNC has agency over (Thailand venue depth, international disclosure framework adoption, DEI policy explicitness) and lower weight on audit / scale signals that depend on company size.
How Roche Holding AGis showing up for Thailand's LGBTQ+ community
Inclusion Dividend
Not yet enrolled
Creator partners
0
verified Thai KOLs
Audit history
No audit yet
Thailand presence
Single market presence
PrideShow LGBTQ+ ESG score (global) — Thailand-specific signals are above
86
Platinum · A+
LGBTQ+ Policy
100
Supply Chain
75
Community
70
Reporting
100
2023 Annual Report — GRI / TCFD / CDP / SASB aligned
CDP Climate A-List (multi-year)
DJSI World + Europe + FTSE4Good Index constituent
Bloomberg Gender-Equality Index constituent
Roche Pride — LGBTQ+ Employee Resource Group
Access to Medicines Index top-3 ranked
Signatory to UN Global Compact + Paris Pledge
Roche Foundation for the Independence of Elderly Care
Committed to net-zero emissions by 2045 (validated SBTi)
Partnerships with Doctors Without Borders + Malaria No More
Reach Roche Holding AG's Thailand and APAC teams through PrideShow. Whether you're an NGO with a partnership idea, an SME on the supplier path, or a fellow MNC exploring co-activation — start the conversation here.
Is this your company?
Claim the listing to manage your Thailand inclusion evidence, respond to inbound enquiries, and connect with NGO and creator partners. Or sponsor PrideShow 2026 directly.
